Mouse Splenocytes CD8+ T Cells

Cat.No.: CSC-C4459X

Species: Mouse

Source: Spleen

Cell Type: T Cell; Lymphocyte

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4459X
Description
Mouse spleen is dissociated into a single cell suspension. The splenocytes are enriched by density separation. CD4+ T cells, CD8+T Cells, and CD19+ B Cells are isolated using specific immunomagnetic methods.
Species
Mouse
Source
Spleen
Cell Type
T Cell; Lymphocyte
Disease
Normal
Storage and Shipping
Ship in dry ice and store in liquid nitrogen
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Mouse splenocyte-derived CD8+ T cells represent a primary, physiologically relevant model for studying cytotoxic T lymphocyte biology. Isolated via magnetic bead or flow cytometric sorting from the spleen-a reservoir rich in naïve and effector/memory T cells-these cells offer distinct advantages: 1) High yield and purity, enabling robust ex vivo functional assays such as IFN-γ ELISpot, degranulation (CD107a), and real-time killing assays; 2) Genetic tractability, as cells from transgenic or knockout mice (e.g., OT-I, P14) allow precise dissection of TCR specificity and signaling pathways; 3) Translational relevance, closely mirroring in vivo priming and exhaustion phenotypes observed in infection and tumor models; and 4) Experimental flexibility, supporting both acute stimulation and long-term expansion cultures. Their ease of isolation and well-defined surface markers make them an indispensable tool for preclinical immunotherapy development and mechanistic immunology studies.

Glutamate Receptor-T Cell Receptor Signaling Potentiates Full CD8+ T Cell Activation and Effector Function in Tumor Immunity

Glutamate is best known as an excitatory neurotransmitter. However, its roles in T cell immunity remain underrecognized. We investigated the interplay between glutamate receptors (GluRs) and T cell receptors (TCRs) during CD8+ T cell activation. Our findings reveal that GluR expression in CD8+ T lymphocytes strongly correlates with the activation of TCR-CD28 signaling, enhancing their antitumor effector responses. Conversely, pharmacologic antagonism of GluRs in activated CD8+ T cells disrupts the colocalization of GluR with TCRVβ8.1, reduces the phosphorylation of TCR-signaling intermediates, alters calcium flux, and impairs the metabolic switch to glycolysis essential for T cell activation. Moreover, these disruptions blunt clonal proliferation and compromise the tumor-cytolytic capacity of CD8+ T cells. Thus, the glutamatergic system-via the GluR-TCR signaling complex-plays a critical amplifier role in activating CD8+ T cells and eliciting their full antitumor activity. This mechanistic insight reveals a previously underappreciated axis in T cell biology and opens avenues for immunotherapy regimens targeting GluR-TCR interactions to augment T cell-mediated responses in cancer and potentially other immunopathologies.

Activated CD8+ T cells co-express and colocalize mGluR1 and T cell receptor.

Fig. 1. Activated and naive CD8+ T cells express GluR, but only activated CD8+ T cells exhibit co-occurrence between TCR and GluR (de Aquino, Maria Teresa P., et al., 2025).

mGluR1 expression correlates with CD8+ T cell activation and effector memory differentiation in suppressive tumor microenvironment.

Fig. 2. mGluR1 expression is associated with CD8+ T cell activation and effector memory differentiation, highlighting its potential to counteract suppressive tumor microenvironment (de Aquino, Maria Teresa P., et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products